GlaxoSmithKline Pharmaceuticals Share Price

Analyst meet Presentation

• BSE India
• 4 hours 57 minutes ago

<h3><span style="font-size:16px;"><strong>Pharmaceuticals company GlaxoSmithKline Pharmaceuticals announced Q2FY27 results</strong></span><br /> <!--TgQPHd|||[[2,[null,null,1,null,null,null,null,null,null,null,null,null,[351768,null,0]],[],null,1]]--></h3> <p><!--TgQPHd|||[]--></p> <p><strong>Standalone Financial Highlights:</strong><!--TgQPHd|||[]--></p> <ul data-complete="true" data-hveid="CAAIEBAA" data-processed="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="wiLEJc#NS0kde" jsuid="A4sHr_3k"> <li data-complete="true" data-hveid="CAAIEBAC" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="A4sHr_3n">Revenue from Operations:<!--TgQPHd|||[]--> For Q2FY27<!--TgQPHd|||[]-->, Standalone Revenue from Operations recorded Rs 1,17,991 lakh, showing a QoQ growth of 27.64% from Rs 92,442 lakh in Q1FY27 and a YoY growth of 21.19% from Rs 97,363 lakh in Q2FY26; for H1FY27<!--TgQPHd|||[]-->, it stood at Rs 2,10,433 lakh, reflecting a 18.32% YoY rise from Rs 1,77,846 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIEBAC" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="A4sHr_3n">Total Income:<!--TgQPHd|||[]--> For Q2FY27<!--TgQPHd|||[]-->, Total Income arrived at Rs 1,25,268 lakh, rising 27.04% QoQ against Rs 98,605 lakh in Q1FY27 and 24.66% YoY against Rs 1,00,490 lakh in Q2FY26; for H1FY27<!--TgQPHd|||[]-->, Total Income reached Rs 2,23,873 lakh, representing a YoY increase of 20.78% from Rs 1,85,349 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIEBAC" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="A4sHr_3n">Profit Before Tax (PBT):<!--TgQPHd|||[]--> For Q2FY27<!--TgQPHd|||[]-->, PBT stood at Rs 45,758 lakh, showing a QoQ increase of 35.39% from Rs 33,798 lakh in Q1FY27 and a YoY increase of 30.49% from Rs 35,065 lakh in Q2FY26; for H1FY27<!--TgQPHd|||[]-->, PBT registered Rs 79,556 lakh, marking a 26.44% YoY milestone compared to Rs 62,922 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIEBAC" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="A4sHr_3n">Profit After Tax (PAT):<!--TgQPHd|||[]--> For Q2FY27<!--TgQPHd|||[]-->, PAT recorded Rs 33,462 lakh, climbing 32.09% QoQ from Rs 25,333 lakh in Q1FY27 and 31.22% YoY from Rs 25,500 lakh in Q2FY26; for H1FY27<!--TgQPHd|||[]-->, PAT arrived at Rs 58,795 lakh, reflecting a 27.90% YoY increase over Rs 45,970 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIEBAC" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="A4sHr_3n">Earnings Per Share (EPS):<!--TgQPHd|||[]--> For Q2FY27<!--TgQPHd|||[]-->, Basic and diluted EPS after Exceptional Items stood at Rs 19.76, an increase of 32.17% QoQ from Rs 14.95 in Q1FY27 and an increase of 31.21% YoY from Rs 15.06 in Q2FY26; for H1FY27<!--TgQPHd|||[]-->, EPS recorded Rs 34.71, up 27.89% YoY compared to Rs 27.14 in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <!--TgQPHd|||[]--> </ul> <p><!--TgQPHd|||[]--></p> <p><strong>Consolidated Financial Highlights:</strong><!--TgQPHd|||[]--></p> <ul data-complete="true" data-hveid="CAAIEBAA" data-processed="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="wiLEJc#NS0kde" jsuid="A4sHr_3k"> <li data-complete="true" data-hveid="CAAIEBAC" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="A4sHr_3n">Revenue from Operations:<!--TgQPHd|||[]--> For Q2FY27<!--TgQPHd|||[]-->, Consolidated Revenue from Operations was Rs 1,18,357 lakh, growing 26.12% QoQ from Rs 93,844 lakh in Q1FY27 and 20.78% YoY from Rs 97,994 lakh in Q2FY26; for H1FY27<!--TgQPHd|||[]-->, it reached Rs 2,12,201 lakh, up 18.87% YoY against Rs 178,511 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIEBAC" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="A4sHr_3n">Total Income:<!--TgQPHd|||[]--> For Q2FY27<!--TgQPHd|||[]-->, Total Income captured Rs 1,25,635 lakh, an increase of 27.91% QoQ from Rs 98,220 lakh in Q1FY27 and a rise of 23.96% YoY from Rs 1,01,351 lakh in Q2FY26; for H1FY27<!--TgQPHd|||[]-->, it gathered Rs 2,23,855 lakh, translating into a 20.20% YoY acceleration over Rs 1,86,240 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIEBAC" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="A4sHr_3n">Profit Before Tax (PBT):<!--TgQPHd|||[]--> For Q2FY27<!--TgQPHd|||[]-->, Consolidated PBT printed Rs 45,934 lakh, expanding 42.45% QoQ over Rs 32,245 lakh in Q1FY27 and 29.76% YoY over Rs 35,400 lakh in Q2FY26; for H1FY27<!--TgQPHd|||[]-->, PBT stood at Rs 78,179 lakh, advancing 23.51% YoY from Rs 63,298 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIEBAC" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="A4sHr_3n">Profit After Tax (PAT):<!--TgQPHd|||[]--> For Q2FY27<!--TgQPHd|||[]-->, Consolidated PAT printed Rs 33,588 lakh, moving up 41.61% QoQ from Rs 23,718 lakh in Q1FY27 and up 30.44% YoY from Rs 25,749 lakh in Q2FY26; for H1FY27<!--TgQPHd|||[]-->, PAT finalized at Rs 57,306 lakh, scaling up by 23.90% YoY compared to Rs 46,250 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIEBAC" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="A4sHr_3n">Earnings Per Share (EPS):<!--TgQPHd|||[]--> For Q2FY27<!--TgQPHd|||[]-->, Consolidated Basic and diluted EPS after Exceptional items came in at Rs 19.83, expanding 41.64% QoQ from Rs 14.00 in Q1FY27 and 30.46% YoY from Rs 15.20 in Q2FY26; for H1FY27<!--TgQPHd|||[]-->, EPS recorded Rs 33.83, exhibiting a 23.92% YoY growth from Rs 27.30 in H1FY26.</li> </ul> <p><strong>Bhushan Akshikar, Managing Director, GSK India, said:</strong> “Our strong performance this quarter reflects the robust execution of our strategy to build a science-first, innovation-led business. Resilient growth across our diversified portfolio underscores the strength of our trusted brands, the increasing contribution of innovative therapies and the scientific rigour demonstrated by our people.”</p> <p>“In line with global priorities, we continue to accelerate our efforts on late-stage pipeline assets, build momentum for our key launches across Oncology and Adult Vaccination, and simplify our ways of working. At the same time, amidst a dynamic geopolitical environment that continues to drive inflationary pressures and supply chain risks, we stay focused on building resilience across our business.”</p> <p><a class="lb" href="/get-document/post/pdf/5927362/" target="_blank">Result PDF</a></p>

• Trendlyne
• 6 hours 6 minutes ago

As per attachment

• BSE India
• 23 hours 4 minutes ago